{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:09:15Z","timestamp":1794866955081,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2020-164"],"award-info":[{"award-number":["BJ-2020-164"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To compare the genomic testing based on specimens obtained from percutaneous core-needle biopsy (CNB) before and immediately after coaxial microwave ablation (MWA) in solid non-small cell lung cancer (NSCLC), and to investigate the diagnostic performance of CNB immediately after coaxial MWA in solid NSCLC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Coaxial MWA and CNB were performed for NSCLC patients, with a power of 30 or 40 watts (W) in MWA between the pre- and post-ablation CNB, followed by continuous ablation after the second CNB on demand. The paired specimens derived from the same patient were compared for pathological diagnosis and genomic testing. DNA\/RNA extracted from the paired specimens were also compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 33 NSCLC patients with solid lesions were included. There were two patients (6.1%) without atypical cells and three patients (9.1%) who had the technical failure of genomic testing in post-ablation CNB. The concordance rate of pathological diagnosis between the twice CNB was 93.9% (kappa\u2009=\u20090.852), while that of genomic testing was 90.9% (kappa\u2009=\u20090.891). For the comparisons of DNA\/RNA extracted from pre- and post-ablation CNB in 30 patients, no significant difference was found when the MWA between twice CNB has a power of 30 or 40\u00a0W and ablation time within five minutes (<jats:italic>P<\/jats:italic>\u2009=\u20090.174).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>If the pre-ablation CNB presented with a high risk of pneumothorax or hemorrhage, the post-ablation CNB could be performed to achieve accurate pathological diagnosis and genomic testing and the maximum effect of ablation, which might allow for the diagnosis of genomic testing in 90.9% of solid NSCLC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40644-023-00610-6","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:03:23Z","timestamp":1696334603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Percutaneous core-needle biopsy before and immediately after coaxial microwave ablation in solid non-small cell lung cancer: the comparison of genomic testing from specimens"],"prefix":"10.1186","volume":"23","author":[{"given":"Sheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Lei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xin","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"3","key":"610_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Ca: a Cancer. J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"J Clin"},{"issue":"1","key":"610_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2(1):1\u20139. https:\/\/doi.org\/10.1016\/j.jncc.2022.02.002.","journal-title":"J Natl Cancer Cent"},{"key":"610_CR3","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer statistics. 2022. Ca-Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","DOI":"10.3322\/caac.21708"},{"issue":"suppl 5","key":"610_CR4","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","volume":"27","author":"S Novello","year":"2016","unstructured":"Novello S, Barlesi F, Califano R, Cufer T, Ekman S, Levra MG, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v1\u201327. https:\/\/doi.org\/10.1093\/annonc\/mdw326.","journal-title":"Ann Oncol"},{"issue":"30","key":"610_CR5","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1200\/JCO.2017.74.6065","volume":"35","author":"N Hanna","year":"2017","unstructured":"Hanna N, Johnson D, Temin S, Baker SJ, Brahmer J, Ellis PM, et al. Systemic therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(30):3484\u2013515. https:\/\/doi.org\/10.1200\/JCO.2017.74.6065.","journal-title":"J Clin Oncol"},{"key":"610_CR6","unstructured":"Non-Small Cell Lung Cancer. Clinical Practice Guidelines in Oncology. NSCLC 2022 V5."},{"issue":"1","key":"610_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12931-023-02321-9","volume":"24","author":"FJ Fintelmann","year":"2023","unstructured":"Fintelmann FJ, Martin NA, Tahir I, Quinn EM, Allen TC, Joseph L, et al. Optimizing molecular testing of lung cancer needle biopsy specimens: potential solutions from an interdisciplinary qualitative study. Resp Res. 2023;24(1):17. https:\/\/doi.org\/10.1186\/s12931-023-02321-9.","journal-title":"Resp Res"},{"issue":"5","key":"610_CR8","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1007\/s00330-019-06613-x","volume":"30","author":"Z Wei","year":"2020","unstructured":"Wei Z, Yang X, Ye X, Feng Q, Xu Y, Zhang L, et al. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. Eur Radiol. 2020;30(5):2692\u2013702. https:\/\/doi.org\/10.1007\/s00330-019-06613-x.","journal-title":"Eur Radiol"},{"key":"610_CR9","doi-asserted-by":"publisher","unstructured":"Kerr KM, Bubendorf L, Edelman MJ, Marchetti A, Mok T, Novello S et al. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol. 2014;25(9):1681-90. https:\/\/doi.org\/10.1093\/annonc\/mdu145.","DOI":"10.1093\/annonc\/mdu145"},{"issue":"1088","key":"610_CR10","doi-asserted-by":"publisher","first-page":"20170946","DOI":"10.1259\/bjr.20170946","volume":"91","author":"S Yun","year":"2018","unstructured":"Yun S, Kang H, Park S, Kim BS, Park JG, Jung MJ. Diagnostic accuracy and complications of CT-guided core needle lung biopsy of solid and part-solid lesions. Brit J Radiol. 2018;91(1088):20170946. https:\/\/doi.org\/10.1259\/bjr.20170946.","journal-title":"Brit J Radiol"},{"issue":"3","key":"610_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/1759-7714.13795","volume":"12","author":"F Kong","year":"2021","unstructured":"Kong F, Wang C, Li Y, Li X. Advances in study of the sequence of lung tumor biopsy and thermal ablation. Thorac Cancer. 2021;12(3):279\u201386. https:\/\/doi.org\/10.1111\/1759-7714.13795.","journal-title":"Thorac Cancer"},{"issue":"8","key":"610_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jvir.2021.04.027","volume":"32","author":"SJ Genshaft","year":"2021","unstructured":"Genshaft SJ, Suh RD, Abtin F, Baerlocher MO, Dariushnia SR, Devane AM, et al. Society of Interventional Radiology Quality Improvement Standards on percutaneous ablation of Non-Small Cell Lung Cancer and Metastatic Disease to the lungs. J Vasc Interv Radiol. 2021;32(8):1241\u20132. https:\/\/doi.org\/10.1016\/j.jvir.2021.04.027.","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"610_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00270-021-02782-9","volume":"44","author":"J Chi","year":"2021","unstructured":"Chi J, Ding M, Wang Z, Hu H, Shi Y, Cui D, et al. Pathologic diagnosis and genetic analysis of sequential Biopsy following Coaxial Low-Power Microwave Thermal Coagulation for Pulmonary Ground-Glass opacity nodules. Cardiovasc Inter Rad. 2021;44(8):1204\u201313. https:\/\/doi.org\/10.1007\/s00270-021-02782-9.","journal-title":"Cardiovasc Inter Rad"},{"issue":"8","key":"610_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00270-016-1324-3","volume":"39","author":"T Hasegawa","year":"2016","unstructured":"Hasegawa T, Kondo C, Sato Y, Inaba Y, Yamaura H, Kato M, et al. Diagnostic ability of Percutaneous Needle Biopsy immediately after Radiofrequency ablation for malignant lung tumors: an initial experience. Cardiovasc Inter Rad. 2016;39(8):1187\u201392. https:\/\/doi.org\/10.1007\/s00270-016-1324-3.","journal-title":"Cardiovasc Inter Rad"},{"issue":"4","key":"610_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00270-017-1845-4","volume":"41","author":"T Hasegawa","year":"2018","unstructured":"Hasegawa T, Kondo C, Sato Y, Inaba Y, Yamaura H, Kato M, et al. Pathologic diagnosis and genetic analysis of a lung Tumor Needle Biopsy Specimen obtained immediately after Radiofrequency ablation. Cardiovasc Inter Rad. 2018;41(4):594\u2013602. https:\/\/doi.org\/10.1007\/s00270-017-1845-4.","journal-title":"Cardiovasc Inter Rad"},{"issue":"3","key":"610_CR16","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00330-016-4447-7","volume":"27","author":"L Tselikas","year":"2017","unstructured":"Tselikas L, de Baere T, Deschamps F, Hakime A, Besse B, Teriitehau C, et al. Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation. Eur Radiol. 2017;27(3):1211\u20137. https:\/\/doi.org\/10.1007\/s00330-016-4447-7.","journal-title":"Eur Radiol"},{"issue":"4","key":"610_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4103\/jcrt.JCRT_399_19","volume":"15","author":"J Wang","year":"2019","unstructured":"Wang J, Ni Y, Yang X, Huang G, Wei Z, Li W, et al. Diagnostic ability of percutaneous core biopsy immediately after microwave ablation for lung ground-glass opacity. J Cancer Res Ther. 2019;15(4):755\u20139. https:\/\/doi.org\/10.4103\/jcrt.JCRT_399_19.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"610_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/02656736.2018.1494856","volume":"35","author":"Z Wei","year":"2018","unstructured":"Wei Z, Wang Q, Ye X, Yang X, Huang G, Li W, et al. Microwave ablation followed by immediate biopsy in the treatment of non-small cell lung cancer. Int J Hyperther. 2018;35(1):262\u20138. https:\/\/doi.org\/10.1080\/02656736.2018.1494856.","journal-title":"Int J Hyperther"},{"issue":"1","key":"610_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2015.09.009.","journal-title":"J Thorac Oncol"},{"issue":"11","key":"610_CR20","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.jvir.2020.07.012","volume":"31","author":"RA Sheth","year":"2020","unstructured":"Sheth RA, Baerlocher MO, Connolly BL, Dariushnia SR, Shyn PB, Vatsky S, et al. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients. J Vasc Interv Radiol. 2020;31(11):1840\u20138. https:\/\/doi.org\/10.1016\/j.jvir.2020.07.012.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"610_CR21","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.21037\/qims-21-1043","volume":"12","author":"S Xu","year":"2022","unstructured":"Xu S, Bie ZX, Li YM, Li B, Peng JZ, Kong FL, et al. Computed tomography-guided microwave ablation for non-small cell lung cancer patients on antithrombotic therapy: a retrospective cohort study. Quant Imag Med Surg. 2022;12(6):3251\u201363. https:\/\/doi.org\/10.21037\/qims-21-1043.","journal-title":"Quant Imag Med Surg"},{"issue":"12","key":"610_CR22","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1111\/1759-7714.14461","volume":"13","author":"F Kong","year":"2022","unstructured":"Kong F, Li Y, Guo R, Yang L, Di J, He L, et al. Liquid biopsy assay for pulmonary adenocarcinoma using supernatants from core-needle biopsy specimens. Thorac Cancer. 2022;13(12):1822\u20136. https:\/\/doi.org\/10.1111\/1759-7714.14461.","journal-title":"Thorac Cancer"},{"key":"610_CR23","unstructured":"Common Terminology Criteria for Adverse. Events (CTCAE) v5.0. Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed June 7, 2023."},{"issue":"7689","key":"610_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"610_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.critrevonc.2019.02.006","volume":"136","author":"G Rosas","year":"2019","unstructured":"Rosas G, Ruiz R, Araujo JM, Pinto JA, Mas L. ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer. Crit Rev Oncol Hemat. 2019;136:48\u201355. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.02.006.","journal-title":"Crit Rev Oncol Hemat"},{"issue":"2","key":"610_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3978\/j.issn.2218-6751.2014.11.11","volume":"4","author":"T Kohno","year":"2015","unstructured":"Kohno T, Nakaoku T, Tsuta K, Tsuchihara K, Matsumoto S, Yoh K, et al. Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. Transl Lung Cancer R. 2015;4(2):156\u201364. https:\/\/doi.org\/10.3978\/j.issn.2218-6751.2014.11.11.","journal-title":"Transl Lung Cancer R"},{"issue":"4","key":"610_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3816\/CLC.2010.n.032","volume":"11","author":"N Kothary","year":"2010","unstructured":"Kothary N, Bartos JA, Hwang GL, Dua R, Kuo WT, Hofmann LV. Computed tomography-guided percutaneous needle biopsy of indeterminate pulmonary pathology: efficacy of obtaining a diagnostic sample in immunocompetent and immunocompromised patients. Clin Lung Cancer. 2010;11(4):251\u20136. https:\/\/doi.org\/10.3816\/CLC.2010.n.032.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"610_CR28","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/02656736.2022.2140840","volume":"39","author":"X Moll","year":"2022","unstructured":"Moll X, Fondevila D, Garcia-Arnas F, Burdio F, Trujillo M, Irastorza RM, et al. Comparison of two radiofrequency-based hemostatic devices: saline-linked bipolar vs. cooled-electrode monopolar. Int J Hyperther. 2022;39(1):1397\u2013407. https:\/\/doi.org\/10.1080\/02656736.2022.2140840.","journal-title":"Int J Hyperther"},{"issue":"6","key":"610_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000342874","volume":"84","author":"T Schneider","year":"2012","unstructured":"Schneider T, Puderbach M, Kunz J, Bischof A, Giesel FL, Dienemann H, et al. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients. Respiration. 2012;84(6):501\u20138. https:\/\/doi.org\/10.1159\/000342874.","journal-title":"Respiration"},{"issue":"7","key":"610_CR30","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.4103\/jcrt.JCRT_721_18","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang D, Li B, Bie Z, Li Y, Li X. Synchronous core-needle biopsy and microwave ablation for highly suspicious malignant pulmonary nodule via a coaxial cannula. J Cancer Res Ther. 2019;15(7):1484\u20139. https:\/\/doi.org\/10.4103\/jcrt.JCRT_721_18.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"610_CR31","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1148\/radiol.2313030347","volume":"231","author":"K Yasui","year":"2004","unstructured":"Yasui K, Kanazawa S, Sano Y, Fujiwara T, Kagawa S, Mimura H, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231(3):850\u20137. https:\/\/doi.org\/10.1148\/radiol.2313030347.","journal-title":"Radiology"},{"issue":"12","key":"610_CR32","doi-asserted-by":"publisher","first-page":"e53158","DOI":"10.1371\/journal.pone.0053158","volume":"7","author":"Q Wang","year":"2012","unstructured":"Wang Q, Huang J, Ma K, Li T, Chen M, Wang S, et al. Evaluation of ghost cell survival in the area of radiofrequency ablation. PLoS ONE. 2012;7(12):e53158. https:\/\/doi.org\/10.1371\/journal.pone.0053158.","journal-title":"PLoS ONE"},{"issue":"11","key":"610_CR33","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/cncr.23882","volume":"113","author":"S Clasen","year":"2008","unstructured":"Clasen S, Krober SM, Kosan B, Aebert H, Fend F, Bomches A, et al. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer-Am Cancer Soc. 2008;113(11):3121\u20139. https:\/\/doi.org\/10.1002\/cncr.23882.","journal-title":"Cancer-Am Cancer Soc"},{"key":"610_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semcancer.2016.03.004","volume":"37\u201338","author":"T Mantso","year":"2016","unstructured":"Mantso T, Goussetis G, Franco R, Botaitis S, Pappa A, Panayiotidis M. Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies. Semin Cancer Biol. 2016;37\u201338:96\u2013105. https:\/\/doi.org\/10.1016\/j.semcancer.2016.03.004.","journal-title":"Semin Cancer Biol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-023-00610-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-023-00610-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-023-00610-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T20:06:58Z","timestamp":1700338018000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-023-00610-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1186\/s40644-023-00610-6","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"16 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional ethics review board approved this study. Informed Consent was waived due to the retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}